NFE2L2 and cancer: On the other hand, decreased expression or altered function of the enzymes that are part of the Nrf2 signaling pathway can lead to differential susceptibility to disease [29] while mutations in the Nrf2 signaling pathway have been shown to be an effective mechanism for cancer cells to evade chemotherapy.